Skip to main content

Articles

1215 result(s) for 'cancer' within Journal of Ovarian Research

Page 7 of 25

  1. The most important prognostic factor in the ovarian cancer is optimal cytoreduction. The neoadjuvant chemotherapy,...

    Authors: Anita Monika Chudecka-Głaz, Aneta Alicja Cymbaluk-Płoska, Janusz Leszek Menkiszak, Agnieszka Monika Sompolska-Rzechuła, Aleksandra Izabela Tołoczko-Grabarek and Izabella Anna Rzepka-Górska
    Citation: Journal of Ovarian Research 2014 7:62
    Content type: Research Published on:

  2. The human RECQ DNA helicase family is involved in genomic stability. Gene mutations of RECQL2, RECQL3, and RECQL4 are associated with genetic disorders and induce early aging and carcinogenesis. Although previous...

    Authors: Yoko Matsushita, Yoshihito Yokoyama, Hidemi Yoshida, Yuki Osawa, Makito Mizunuma, Tatsuhiko Shigeto, Masayuki Futagami, Tadaastu Imaizumi and Hideki Mizunuma
    Citation: Journal of Ovarian Research 2014 7:107
    Content type: Research Published on:

  5. This review describes the use of polymer micelle nanotechnology based chemotherapies for ovarian cancer. While various chemotherapeutic agents can be utilized ... improve the survival rate of patients with ovaria...

    Authors: Murali M Yallapu, Meena Jaggi and Subhash C Chauhan
    Citation: Journal of Ovarian Research 2010 3:19
    Content type: Review Published on:

  6. Ovarian carcinoma is the second most common malignancy of the female reproductive system and the leading cause of death from female reproductive system malignancies. Cancer cells have increased proliferation rate...

    Authors: Nour El-Mais, Isabelle Fakhoury, Sandra Abdellatef, Ralph Abi-Habib and Mirvat El-Sibai
    Citation: Journal of Ovarian Research 2021 14:13
    Content type: Research Published on:

  7. Accumulating data have established that microRNAs (miRNAs) play significant regulatory roles in the carcinogenesis and progression of ovarian cancer (OC). MiR-425-5p was reported to function in various tumors. Ho...

    Authors: Zhihui Wu, Jianlin Guo, Ying Zhang, Jianhua Liu, Hongping Ma and Yurong Tang
    Citation: Journal of Ovarian Research 2021 14:138
    Content type: Research Published on:

  8. Emerging evidence has highlighted the biological significance of pyroptosis in tumor tumorigenesis and progression. Nonetheless, the potential roles of pyroptosis in tumor immune microenvironment and target thera...

    Authors: Lingling Gao, Feiquan Ying, Jing Cai, Minggang Peng, Man Xiao, Si Sun, Ya Zeng, Zhoufang Xiong, Liqiong Cai, Rui Gao and Zehua Wang
    Citation: Journal of Ovarian Research 2023 16:27
    Content type: Research Published on:

  10. ETS transcription factors are known to act as either positive or negative regulators of the expression of genes involved in various biological processes. It was reported that ETS variant transcription factor 5 (E...

    Authors: Lu Zhang, Ruiting Fu, Ping Liu, Lijun Wang, Weihua Liang, Hong Zou, Wei Jia and Lin Tao
    Citation: Journal of Ovarian Research 2021 14:149
    Content type: Research Published on:

  12. Ferroptosis and iron-metabolism are regulated by Long non-coding RNAs (lncRNAs) in ovarian cancer (OC). Therefore, a comprehensive analysis...

    Authors: Songwei Feng, Han Yin, Ke Zhang, Mei Shan, Xuan Ji, Shanhui Luo and Yang Shen
    Citation: Journal of Ovarian Research 2022 15:10
    Content type: Research Published on:

  18. The human umbilical cord mesenchymal stem cells (hUCMSCs) have the ability to migrate into tumors and therefore have been considered as an alternative source of mesenchymal progenitors for the therapy of malignan...

    Authors: Yunxia Zhang, Jing Wang, Mulan Ren, Miao Li, Dengyu Chen, Junsong Chen, Fangfang Shi, Xiaoying Wang and Jun Dou
    Citation: Journal of Ovarian Research 2014 7:8
    Content type: Research Published on:

  19. Small nucleolar RNA host gene 25 (SNHG25), a long noncoding RNA, has been well-studied in epithelial ovarian cancer. However, the specific functions of SNHG25 in endometrial cancer (EC) have not been studied yet....

    Authors: Yuhua He, Shuifang Xu, Yi Qi, Jinfang Tian and Fengying Xu
    Citation: Journal of Ovarian Research 2021 14:163
    Content type: Research Published on:

  20. Ovarian cancer (OV), the most fatal gynecological malignance...n = 372) and normal controls (n = 180). Based on the LASSO-Cox analysis, we distinguished a 2-gene prognostic signature, namely FOXO1 and CASP8, with...

    Authors: Jiani Yang, Chao Wang, Yue Zhang, Shanshan Cheng, Meixuan Wu, Sijia Gu, Shilin Xu, Yongsong Wu and Yu Wang
    Citation: Journal of Ovarian Research 2023 16:86
    Content type: Research Published on:

  21. Serous ovarian cancer (SOC) is the most common women cancer and the leading cause of cancer-related mortality among the gynaecological malignancies. Although ... or indicator of drug resistance in serous ovarian

    Authors: Jing Zhang, Suhong Xie, Lei Zhou, Xiaoyu Tang, Xiaolin Guan, Minjie Deng, Hui Zheng, Yanchun Wang, Renquan Lu and Lin Guo
    Citation: Journal of Ovarian Research 2021 14:122
    Content type: Research Published on:

  25. To evaluate the efficacy and safety of PLD in treating of in patients who experience epithelial ovarian, fallopian tubal, and peritoneal cancer progression within 12 months after the first-...

    Authors: Zhen Yuan, Ying Zhang, Dongyan Cao, Keng Shen, Qingshui Li, Guonan Zhang, Xiaohua Wu, Manhua Cui, Ying Yue, Wenjun Cheng, Li Wang, Pengpeng Qu, Guangshi Tao, Jianqing Hou, Lixin Sun, Yuanguang Meng…
    Citation: Journal of Ovarian Research 2021 14:12
    Content type: Research Published on:

  26. There is no consensus regarding the management of ovarian cancer patients, who have shown complete clinical response ... (CCR) to primary therapy and have rising cancer antigen CA-125 levels but have no...

    Authors: Fang Wang, Yanfen Ye, Xia Xu, Xuehui Zhou, Jinhua Wang and Xiaoxiang Chen
    Citation: Journal of Ovarian Research 2013 6:14
    Content type: Research Published on:

  27. The aim of this meta-analysis was to assess the effectiveness and safety of secondary cytoreductive surgery plus chemotherapy (SCS + CT) in recurrent ovarian cancer (ROC). Our secondary purpose was to...

    Authors: Ting Ding, Dan Tang and Mingrong Xi
    Citation: Journal of Ovarian Research 2021 14:93
    Content type: Review Published on:

  28. We conducted a survey among women with ovarian cancer at their first follow-up visit or ... (MaNGO) and Multicenter Italian Trials in Ovarian Cancer (MITO) groups. A questionnaire on knowledge ... process involvi...

    Authors: Paola Mosconi, Anna Roberto, Nicoletta Cerana, Nicoletta Colombo, Florence Didier, Maurizio D’Incalci, Domenica Lorusso and Fedro Alessandro Peccatori
    Citation: Journal of Ovarian Research 2022 15:45
    Content type: Research Published on:

  29. Optimal debulking surgery is postulated to be useful in survival of ovarian cancer patients. Some studies highlighted the possible role ... bowel involvement in patients with advanced epithelial ovarian cancer wh...

    Authors: Giorgio Giorda, Angiolo Gadducci, Emilio Lucia, Roberto Sorio, Valentina E Bounous, Francesco Sopracordevole, Andrea Tinelli, Gustavo Baldassarre and Elio Campagnutta
    Citation: Journal of Ovarian Research 2014 7:72
    Content type: Research Published on:

  31. Polycystic ovary syndrome (PCOS) is an endocrine disorder characterized by ovarian cysts, high androgen levels, and irregular menstruation. The causality between PCOS and breast cancer (BC) has been widely discus...

    Authors: Runxiang Cao, Lanlan Chen, Yutong Liu, Xuyutian Wang, Ruolin Ma, Qian Zhao and Ye Du
    Citation: Journal of Ovarian Research 2023 16:215
    Content type: Research Published on:

  33. Angiopoietin-like 4 (ANGPTL4) is highly expressed in a variety of neoplasms and promotes cancer progression. Nevertheless, the mechanism of ANGPTL4 in ovarian cancer (OC) metastasis remains unclear. This study...

    Authors: Yinping Liu, Rui Yang, Yan Zhang, Yaping Zhu and Wei Bao
    Citation: Journal of Ovarian Research 2022 15:131
    Content type: Research Published on:

  34. Exosomal miRNAs regulate gene expression and play important roles in several diseases. We used exosomal miRNA profiling to investigate diagnostic biomarkers of epithelial ovarian cancer (EOC).

    Authors: Jingjing Liu, Jigeun Yoo, Jung Yoon Ho, Yuyeon Jung, Sanha Lee, Soo Young Hur and Youn Jin Choi
    Citation: Journal of Ovarian Research 2021 14:59
    Content type: Research Published on:

  35. The results showed that the number of preoperative white blood cells (p = 0.022), monocytes (p < 0.001), lymphocytes (p < 0.001), neutrophils (p < 0.001), and eosinophils (p...< 0.001) and the monocyte to lymphoc...

    Authors: Ying Feng, Zhixiang Wang, Ran Cui, Meizhu Xiao, Huiqiao Gao, Huimin Bai, Bert Delvoux, Zhen Zhang, Andre Dekker, Andrea Romano, Shuzhen Wang, Alberto Traverso, Chongdong Liu and Zhenyu Zhang
    Citation: Journal of Ovarian Research 2022 15:64
    Content type: Research Published on:

  36. STAT3 and p-STAT3 are often overexpressed in various human tumours and participate in cancer development and progression. However, whether STAT3/ ... has prognostic significance for people suffering from ovarian

    Authors: Shuo Gao, Wenyuan Zhang, Na Yan, Min Li, Xiaowei Mu, Huaxia Yin and Jinhua Wang
    Citation: Journal of Ovarian Research 2021 14:164
    Content type: Review Published on:

  37. Ovarian cancer is composed of a complex system of ... , thus making it the most lethal gynecologic cancer. Seminal work on cancer as an evolutionary process has a long ... that focused on the clonal evolution of ...

    Authors: Patriciu Achimas-Cadariu, Paul Kubelac, Alexandru Irimie, Ioana Berindan-Neagoe and Frank Rühli
    Citation: Journal of Ovarian Research 2022 15:67
    Content type: Review Published on:

  39. In recent years, silver nanoparticles (AgNPs) have gradually been widely used, especially in the field of anticancer medicine. Ovarian cancer (OC) is the gynaecological malignancy with...

    Authors: Man Yin, Xiangyu Xu, Hui Han, Jiahui Dai, Ronghe Sun, Linqing Yang, Junyu Xie and Yunfei Wang
    Citation: Journal of Ovarian Research 2022 15:121
    Content type: Research Published on:

  40. Despite advances in medical imaging technology, the accurate preoperative prediction of lymph node status remains challenging in ovarian cancer. This retrospective study aimed to investigate the ... ) in patients...

    Authors: Yue Qi, Jinchi Liu, Xinyue Wang, Yuqing Zhang, Zhixun Li, Xinyu Qi and Ying Huang
    Citation: Journal of Ovarian Research 2024 17:48
    Content type: Research Published on:

  41. Ovarian cancer is the leading cause of death from gynecologic cancer in women worldwide. According to the National Cancer Institute, ovarian cancer has the highest mortality rate among all the reproductive cancers

    Authors: Smriti Kumar, Arooshi Kumar, Parag P Shah, Shesh N Rai, Siva K Panguluri and Sham S Kakar
    Citation: Journal of Ovarian Research 2011 4:17
    Content type: Research Published on:

  43. Resistance to current chemotherapeutic agents is a major cause of therapy failure in ovarian cancer patients, but the exact mechanisms leading to...

    Authors: Cheryl A Sherman-Baust, Kevin G Becker, William H Wood III, Yongqing Zhang and Patrice J Morin
    Citation: Journal of Ovarian Research 2011 4:21
    Content type: Research Published on:

  45. We aimed to evaluate the prognostic value of C-C motif chemokine receptor type 5 (CCR5) expression level for patients with ovarian cancer and to establish a radiomics model that can predict CCR5 expression level ...

    Authors: Sheng Wan, Tianfan Zhou, Ronghua Che, Ying Li, Jing Peng, Yuelin Wu, Shengyi Gu, Jiejun Cheng and Xiaolin Hua
    Citation: Journal of Ovarian Research 2023 16:1
    Content type: Research Published on:

  46. The Dachshund homolog 2 (DACH2...) gene has been implicated in development of the female genital tract in mouse models and premature ovarian failure syndrome, but to date, its expression in human normal and cance...

    Authors: Björn Nodin, Marie Fridberg, Mathias Uhlén and Karin Jirström
    Citation: Journal of Ovarian Research 2012 5:6
    Content type: Research Published on:

  47. Studies of alternative mRNA splicing (AS) in health and disease have yet to yield the complete picture of protein diversity and its role in physiology and pathology. Some forms of cancer appear to be associated t...

    Authors: Sergio Juárez-Méndez, Alejandro Zentella-Dehesa, Vanessa Villegas-Ruíz, Oscar Alberto Pérez-González, Mauricio Salcedo, Ricardo López-Romero, Edgar Román-Basaure, Minerva Lazos-Ochoa, Víctor Edén Montes de Oca-Fuentes, Guelaguetza Vázquez-Ortiz and José Moreno
    Citation: Journal of Ovarian Research 2013 6:61
    Content type: Research Published on:

  48. Among the pro-inflammatory lipid mediators, platelet-activating factor (PAF) is a major primary and secondary messenger that binds to the PAF-receptor (PAFR). Epidermal growth factor (EGF) is a polypeptide growth...

    Authors: Yi Yu, Xiaoyan Zhang, Shanshan Hong, Mingxing Zhang, Qingqing Cai, Wei Jiang and Congjian Xu
    Citation: Journal of Ovarian Research 2014 7:39
    Content type: Research Published on:

  49. Ovarian cancer (OC) is considered the most lethal gynecological cancer, of which more than 65% cases...

    Authors: Jorge A. Alegría-Baños, José C. Jiménez-López, Arely Vergara-Castañeda, David F. Cantú de León, Alejandro Mohar-Betancourt, Delia Pérez-Montiel, Gisela Sánchez-Domínguez, Mariana García-Villarejo, César Olivares-Pérez, Ángel Hernández-Constantino, Acitlalin González-Santiago, Miguel Clara-Altamirano, Liz Arela-Quispe and Diddier Prada-Ortega
    Citation: Journal of Ovarian Research 2021 14:96
    Content type: Research Published on:

  50. In 2023, the final PAOLA-1 trial (NCT02477644) survival data were published documenting the benefits of therapy consisting of olaparib plus bevacizumab for patients with advanced ovarian cancer (AOC) as a functio...

    Authors: Youwen Zhu, Kun Liu, Hui Cao and Hong Zhu
    Citation: Journal of Ovarian Research 2023 16:168
    Content type: Research Published on:
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.

Journal of Ovarian Research

ISSN: 1757-2215

Contact us